Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Mei Pharma, Inc. (MM) (MSHL)
Mei Pharma, Inc. (MM) (MSHL) Actualités

MSHL

Marshall Edwards (MSHL)

Mei Pharma, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:MSHL

1 2 3 4 5 6 7 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
09/07/2012	20h41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
05/07/2012	22h03	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
02/07/2012	21h18	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
28/06/2012	15h00	PR Newswire (US)	Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
04/06/2012	15h00	PR Newswire (US)	Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
29/05/2012	15h00	PR Newswire (US)	Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
25/05/2012	19h32	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
15/05/2012	16h05	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
14/05/2012	15h00	PR Newswire (US)	Marshall Edwards Completes Rights Offering To Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
08/05/2012	15h00	PR Newswire (US)	Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
25/04/2012	15h00	PR Newswire (US)	Marshall Edwards Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
10/04/2012	15h00	PR Newswire (US)	Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidat...	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
03/04/2012	15h00	PR Newswire (US)	Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual Meeting	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
28/03/2012	15h00	PR Newswire (US)	Marshall Edwards CEO to Present at Needham Healthcare Conference	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
27/03/2012	15h00	PR Newswire (US)	Marshall Edwards Receives Notice of Effectiveness for Rights Offering to Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
27/03/2012	12h02	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
20/03/2012	13h55	Edgar (US Regulatory)	Securities Registration Statement (S-1/A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
19/03/2012	14h00	PR Newswire (US)	Marshall Edwards Announces Terms for Rights Offering to Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
06/03/2012	15h00	PR Newswire (US)	Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
29/02/2012	15h00	PR Newswire (US)	Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
21/02/2012	15h00	PR Newswire (US)	Marshall Edwards Announces Rights Offering to Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
21/02/2012	12h57	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (S-8)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
21/02/2012	12h11	Edgar (US Regulatory)	Securities Registration Statement (S-1)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
14/02/2012	22h12	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
03/01/2012	15h00	PR Newswire (US)	Marshall Edwards Issued New Method of Use Patent for Lead Oncology Drug Candidate ME-344	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
29/12/2011	15h00	PR Newswire (US)	Marshall Edwards Adds $2 Million in Private Placement	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
20/12/2011	15h00	PR Newswire (US)	Marshall Edwards Awarded Key Patent For Compositions Of Lead Oncology Drug Candidates	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
22/11/2011	15h00	PR Newswire (US)	Marshall Edwards to Host Annual Meeting of Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
10/11/2011	15h00	PR Newswire (US)	Marshall Edwards CEO to Present at Lazard Capital Markets Healthcare Conference	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
28/10/2011	17h44	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)

Showing the most relevant articles for your search:NASDAQ:MSHL

1 2 3 4 5 6 7 Suivant >>

Societe Generale

JP Morgan Chase

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales